๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Poster Sessions: Basic Science


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
391 KB
Volume
21
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

โœฆ Synopsis


Objective: To find means to accurately differentiate Parkinson's disease from multiple system atrophy.

Background: In early disease stages it can be clinically difficult to differentiate idiopathic Parkinson's disease (IPD) from patients with multiple system atrophy predominated by parkinsonism (MSA-P).

Methods: In CSF of 31 patients with IPD, 19 patients with MSA-P, we analyzed tau, neurofilament light chain (NFL) and heavy chain (NFHp35) and the noradrenergic metabolite 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG).

Results: CSF levels of NFL, NFHp35, and tau were significantly increased in MSA-P, whereas MHPG levels were significantly decreased in MSA-P. Optimal discriminative cut-off values for the differentiation between MSA-P and IPD were calculated resulting in high sensitivity (76-94%) and specificity (83-97%) levels. Multivariate logistic regression resulted in the combination of NFL and tau as independent contributors in differentiating between MSA-P and IPD with a 95% sensitivity and a 84% specificity.

Conclusion: Higher CSF levels of axonal markers could reflect advanced axonal degeneration in MSA-P. Differentiating MSA-P from IPD is accurately possible with CSF analysis of a combination of axonal and neurotransmitter biomarkers. Patient Characteristics Idiopathic Parkinson's Disease (nฯญ31) MSA-P (n ฯญ 19) Controls P-value Age 52.5 ฯฎ 10.8 59.6 ฯฎ 6.6 52.8 ฯฎ 9.2 0.0006 1 Age at onset 49.5 ฯฎ 10 55.7 ฯฎ 7 NA 0.02 1 Disease duration 3.6 ฯฎ 2.8 4.1 ฯฎ 2.1 NA NS 2 Modified H & Y 1.5 2.5 NA 0.0001 2 SD: Standard deviation, NA: Not applicable, NS: not significant, 1) Unpaired Student's t-test for MSA-P vs. IPD, 2) Mann Whitney test MSA-P vs. IPD values are mean ฯฎ SD unless indicated otherwise. Accuracy numbers with corresponding cutoff values CSF parameter Cutoff value MSA-Pvs IPD TAU ฯพ 227 sensitivity 76 specificity 97 ROC AUC 0.88 likelihood ratio 4.11 NFL ฯพ 17.15 sensitivity 83 specificity 90 ROC AUC 0.92 Likelihood ratio 5.42 NFHp35 ฯพ 114.5 sensitivity 83 specificity 87 ROC AUC 0.88 MHPG ฯฝ 40.5 likelihood ratio 5.23 sensitivity 94 Accuracy numbers with corresponding cutoff values CSF parameter Cutoff value MSA-Pvs IPD specificity 83 ROC AUC 0.91 Likelihood ratio 14.9 ROC AUC: receiver operating curve area under curve P2 Heterozygous PINK1 mutations are a significant risk factor in sporadic PD


๐Ÿ“œ SIMILAR VOLUMES


Poster Sessions: Clinical Science
๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 648 KB

Consistent with our previous (A 2A KO) data in this dyskinesia model (Fredduzzi et al, 2002), the present study also showed that L-DOPAinduced dyskinetic movements were significantly attenuated in a conditional (Cre/loxP system) KO mice lacking postnatal forebrain A 2A receptors. Hence, both pharmac

Poster session 1: A. Basic science, gene
๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 526 KB

Objective: The MPTP-lesioned mouse model of basal ganglia injury was used to investigate the effect of exercise in facilitating neuroplasticity and recovery. In order to elucidate the mechanisms underlying exercise-induced plasticity, the effect of exercise on biochemical, morphological, and behavio

Poster Sessions
๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 386 KB
Poster sessions
๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 714 KB

Those posters identified as AASLD Presidential Poster of Distinction by a ribbon icon have received review scores that place them within the top 10% of all posters. We encourage you to make them a priority as you visit the poster session.

Session 11: Radiopharmacology-Basic Scie
๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 635 KB

Analogues of the macrocyclic chelator 1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetic acid (TETA) are currently used as chelators of choice for labeling copper radionuclides to biological molecules. Recently, the "cross-bridged" cyclam complex, 64 Cu(II)-4,11bis(carboxymethyl)-1,4,8,11-tetraa